A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients with High-Risk Castrate Biochemically Relapsed Prostate Cancer

2011 ◽  
Author(s):  
Scott T. Tagawa
Keyword(s):  
Prostate Cancer ◽  
Monoclonal Antibody ◽  
High Risk ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Randomized Phase 2

659 PHASE 2 TRIAL OF NEOADJUVANT LHRH PLUS ESTRAMUSTINE FOR HIGH RISK PROSTATE CANCER FOLLOWED BY RADICAL PROSTATECTOMY

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Takuya Koie ◽  
Teppei Okamoto ◽  
Kengo Imanishi ◽  
Naoki Sugiyama ◽  
Yuichiro Suzuki ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Radical Prostatectomy ◽  
Phase 2 ◽  
High Risk Prostate Cancer ◽  
Phase 2 Trial ◽  
Risk Prostate Cancer

A randomized phase 2 trial of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with erlotinib in EGFR wild-type NSCLC patients.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8051-8051 ◽  
Author(s):  
Lecia V. Sequist ◽  
Ariel Lopez-Chavez ◽  
Robert Charles Doebele ◽  
Jhanelle Elaine Gray ◽  
Wael A. Harb ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Human Monoclonal Antibody ◽  
Phase 2 ◽  
Wild Type ◽  
Phase 2 Trial ◽  
Antibody Targeting ◽  
Nsclc Patients ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document